Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 6,167 | 51,533 | 9,139 | 5,110 | 730 |
| Cost of Goods | 24 | N/A | N/A | N/A | N/A |
| Gross Profit | 6,143 | 51,533 | 9,139 | 5,110 | 730 |
| Operating Expenses | 119,825 | 120,911 | 107,100 | 109,024 | 90,803 |
| Operating Income | -113,658 | -69,378 | -97,961 | -103,914 | -90,073 |
| Other Income | 2,703 | 3,047 | 3,686 | 4,233 | 2,666 |
| Pre-tax Income | -110,955 | -66,331 | -94,275 | -99,681 | -87,407 |
| Net Income Continuous | -110,955 | -66,331 | -94,275 | -99,681 | -87,407 |
| Net Income | $-110,955 | $-66,331 | $-94,275 | $-99,681 | $-87,407 |
| EPS Basic Total Ops | -2.11 | -1.32 | -1.93 | -2.04 | -1.98 |
| EPS Basic Continuous Ops | -2.11 | -1.32 | -1.93 | -2.04 | -1.98 |
| EPS Diluted Total Ops | -2.11 | -1.32 | -1.93 | -2.04 | -1.98 |
| EPS Diluted Continuous Ops | -2.11 | -1.32 | -1.93 | -2.04 | -1.98 |
| EBITDA(a) | $-112,087 | $-68,387 | $-98,061 | $-104,341 | $-90,227 |